Central Drugs Standard Control Organisation

Watch: Swiss Lab, Gambian Panel Say Maiden Pharma Responsible for Kids’ Deaths

Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin

Expert Panel Recommends Emergency-Use Okay for Covaxin in 2-18 Age Group

CDSCO Expert Panel Gives Nod to Study on Mixing Doses of Covaxin, Covishield

Johnson & Johnson In Talks With Indian Government to Trial Single-Dose Vaccine

Expert Panel Seeks Additional Data From Dr Reddy’s Laboratories on Sputnik V

Covaxin Exits ‘Clinical Trial Mode’, Centre Says